Benjamin Kasenda

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. doi request reprint 18F-FDG PET is an independent outcome predictor in primary central nervous system lymphoma
    Benjamin Kasenda
    Department of Hematology Oncology, Freiburg University Medical Center, Freiburg, Germany
    J Nucl Med 54:184-91. 2013
  2. doi request reprint [Lung cancer screening - an overview about chances and risks]
    Benjamin Kasenda
    Institut für Klinische Epidemiologie und Biostatistik, Universitatsspital Basel
    Ther Umsch 70:237-43; discussion 244. 2013

Detail Information

Publications2

  1. doi request reprint 18F-FDG PET is an independent outcome predictor in primary central nervous system lymphoma
    Benjamin Kasenda
    Department of Hematology Oncology, Freiburg University Medical Center, Freiburg, Germany
    J Nucl Med 54:184-91. 2013
    ..Primary central nervous system (CNS) lymphoma is an aggressive non-Hodgkin lymphoma with poor prognosis. We evaluated pretreatment (18)F-FDG PET as a prognostic marker in primary CNS lymphoma...
  2. doi request reprint [Lung cancer screening - an overview about chances and risks]
    Benjamin Kasenda
    Institut für Klinische Epidemiologie und Biostatistik, Universitatsspital Basel
    Ther Umsch 70:237-43; discussion 244. 2013
    ..Whether LDCT screening is associated with an acceptable incremental cost-effectiveness ratio still warrants further investigation...